In patients with coronary artery disease (CAD) and obesity, tirzepatide was associated with lower mortality and reduced ...

Eli Lilly’s weight loss drugs have delivered blockbuster sales in recent quarters. The company is a leader in this market ...

Eli Lilly could extend its lead in its core therapeutic area with the launch of two new products next year. The company also ...

The underground selling of weight-loss drugs has exploded in line with the booming popularity of medications like Mounjaro ...

One of the reasons for the internal disagreement at the club was the fact that the nutritionist Eduardo Rauen, who has been ...

Bynes has been vocal about her weight-loss journey, which began in June with the trendy GLP-1 agonist drug Ozempic so she ...

The European Medicines Agency (EMA) has recommended extending the use of Mounjaro to younger patients with diabetes, ...

From shifting grocery habits to new product opportunities, Circana’s insights reveal how brands and retailers can adapt to ...

Obesity is a big driver of healthcare spending in South Africa, yet most medical schemes still limit cover for effective ...

A young woman treated for suspected methaemoglobinaemia instead experiences worsening haemolysis that reveals a previously ...

For an older person with type 2 diabetes, especially someone already at risk of frailty, a GLP 1 or SGLT 2 medicine, where ...

The Netherlands launch builds on Biocon's entry into the UK in February, where it received regulatory approval for ...